Companies /Healthcare

DFTX

DFTX Biotechnology
$38.68
▲ $0.83 (+2.19%) today
Markets open · 9:40am ET
Today · % change

Fundamentals

Market Cap
$5.2B
EPS (TTM)
$-3.50
52-Week Range
$9 – $50
Street Target
$71.65

About DFTX

Definium Therapeutics, Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company is headquartered in New York, New York.

DFTX Coverage